Substance / Medication

Chlorpromazine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

63 trials linked to this intervention

63
Total Trials
5
Recruiting
21
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
Webber S K, Domniz Y, Sutton G L et al. · Cornea · 2001
PMID: 11248834Case Report
How sugar types and fabrication methods affect palatability in paediatric-friendly oromucosal pullulan films of chlorpromazine hydrochloride.
Chachlioutaki Konstantina, Li Xiunan, Koltsakidis Savvas et al. · Carbohydr Polym · 2025
PMID: 39562077Other
Functional observational battery (FOB) tests using caffeine and chlorpromazine hydrochloride in sprague-dawley rats.
Baskaran Subramanian, Prakash Malaiarasan, Sanjaykumar Mansukhlal Paneliya · Cell Mol Biol (Noisy-le-grand) · 2024
PMID: 39380284Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Chlorpromazine hydrochloride (substance)
SNOMED CT
387479008
UMLS CUI
C0355077

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

8
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
63
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Chlorpromazine hydrochloride — Conditions, Biomarkers & Specialists | Healos | Healos